Complete Resolution of Disease After Peptide Receptor Radionuclide Therapy in a Patient of Metastatic Insulinoma
| Autor: | Anurag R. Lila, Tushar Bandgar, Manjunath Havalappa Dodamani, Gaurav Malhotra, Priyanka Verma, Ramesh V Asopa |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Carcinoma Hepatocellular Peptide receptor Receptors Peptide Hypoglycemic episodes Disease Octreotide Quality of life Positron Emission Tomography Computed Tomography medicine Organometallic Compounds Humans Radiology Nuclear Medicine and imaging In patient Chemoembolization Therapeutic Radionuclide Imaging Insulinoma Radioisotopes business.industry Liver Neoplasms General Medicine Middle Aged medicine.disease Complete resolution Pancreatic Neoplasms Positron-Emission Tomography Radionuclide therapy Quality of Life Radiology business |
| Zdroj: | Clinical nuclear medicine. 47(1) |
| ISSN: | 1536-0229 |
| Popis: | A 48-year-old man, a case of metastatic insulinoma, who failed transarterial chemoembolization of liver metastases underwent multiple cycles of peptide receptor radionuclide therapy with 177Lu-DOTATATE, following which a complete morphologic and metabolic response was demonstrated on 68Ga-DOTATATE PET/CT. Patient had a remarkable improvement in his quality of life as intractable hypoglycemic episodes resolved after treatment. Peptide receptor radionuclide therapy is a promising targeted radionuclide therapy in patients of metastatic insulinomas that can result in reduced tumor burden and improved quality of life, particularly those who fail the conventional treatment modalities as seen in the present case. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|